YJ001

N/A

Report date: 2023/01/08 19:05:59
NME

Base Information

Drug NameYJ001
Drug Alias NameYJ-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic peripheral neuropathyDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesZhejiang Yuejia Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhejiang Hanmai Pharmaceutical Technology Co LtdYuejia Pharmaceuticals (USA) IncZhejiang Yuejia Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathyDiabetic Neuropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A